Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021;90(2):138-139.
doi: 10.1159/000512311. Epub 2020 Oct 27.

Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis

Teodora Doherty  1 , Ella J Daly  2 , Janice Miller  3 , Vanina Popova  4 , M Soledad Cepeda  5 , Wayne C Drevets  6 , Carla M Canuso  6
Affiliations
Comment

Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis

Teodora Doherty et al. Psychother Psychosom. 2021.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All of the authors are employees of Janssen Research & Development, LLC, or Janssen Scientific Affairs, LLC, and stockholders of Johnson & Johnson, Inc.

Comment in

  • Reply to the Comments by Doherty et al.
    Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G. Gastaldon C, et al. Psychother Psychosom. 2021;90(2):140-141. doi: 10.1159/000511830. Epub 2020 Oct 22. Psychother Psychosom. 2021. PMID: 33091915 No abstract available.

Comment on

References

    1. Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G. Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychother Psychosom. 2020 Aug;:1–8. - PubMed
    1. Spravato® REMS (Risk Evaluation and Mitigation Strategy) [cited 2020 Sep 4]. Available from: https://www.spravatorems.com.
    1. US Food and Drug Administration FDA Adverse Event Reporting System (FAERS) public dashboard. [cited 2020 Sep 4]. Available from: https://www.fda.gov/drugs/questionsand-answers-fdas-adverse-event-report....
    1. Toki T, Ono S. Spontaneous reporting on adverse events by consumers in the United States: an analysis of the Food and Drug Administration Adverse Event Reporting System database. Drugs Real World Outcomes. 2018 Jun;5((2)):117–28. - PMC - PubMed
    1. Feldman RL, Dunner DL, Muller JS, Stone DA. Medicare patient experience with vagus nerve stimulation for treatment-resistant depression. J Med Econ. 2013;16((1)):62–74. - PubMed